Coeptis Therapeutics Holdings (COEP) Enterprise Value (2021 - 2025)
Historic Enterprise Value for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to -$4.8 million.
- Coeptis Therapeutics Holdings' Enterprise Value fell 38776.75% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.8 million, marking a year-over-year decrease of 38776.75%. This contributed to the annual value of -$47783.0 for FY2024, which is 9674.75% up from last year.
- As of Q3 2025, Coeptis Therapeutics Holdings' Enterprise Value stood at -$4.8 million, which was down 38776.75% from -$2.0 million recorded in Q2 2025.
- Coeptis Therapeutics Holdings' 5-year Enterprise Value high stood at -$47783.0 for Q4 2024, and its period low was -$7.4 million during Q3 2022.
- Its 5-year average for Enterprise Value is -$2.2 million, with a median of -$2.0 million in 2025.
- Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 116077.32% in 2022, then skyrocketed by 9674.75% in 2024.
- Over the past 5 years, Coeptis Therapeutics Holdings' Enterprise Value (Quarter) stood at -$2.2 million in 2021, then crashed by 73.95% to -$3.8 million in 2022, then soared by 61.25% to -$1.5 million in 2023, then skyrocketed by 96.75% to -$47783.0 in 2024, then crashed by 9901.44% to -$4.8 million in 2025.
- Its Enterprise Value stands at -$4.8 million for Q3 2025, versus -$2.0 million for Q2 2025 and -$3.3 million for Q1 2025.